After R&D head exits, Immunocore CEO pairs ambition with caution for growing cancer portfolio
After R&D head exits, Immunocore CEO pairs ambition with caution for growing cancer portfolio
After R&D head exits, Immunocore CEO pairs ambition with caution for growing cancer portfolio